Clifford Bechtold
Compliance Officer presso BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Posizioni attive di Clifford Bechtold
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Compliance Officer | - | - |
| Chief Operating Officer | 25/10/2017 | - | |
| BIOHAVEN LTD. | Compliance Officer | - | - |
Storia della carriera di Clifford Bechtold
Precedenti posizioni note di Clifford Bechtold
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/10/2011 | 01/11/2013 |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 01/04/2009 | 01/10/2011 |
Formazione di Clifford Bechtold
| South Dakota State University | Undergraduate Degree |
| The Creighton University School of Medicine | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Compliance Officer | 2 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| BIOHAVEN LTD. | Health Technology |
| Aziende private | 2 |
|---|---|
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Health Technology |
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
- Borsa valori
- Insiders
- Clifford Bechtold
- Esperienza
